Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol
Journal of Clinical Laboratory Analysis · 2026-08 · 40 (15)
DOI: 10.1002/jcla.70280 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 10.06.2026. Verfasst von Huicong Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People's Republic of China. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Antibodies, Heterophile. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Heterophilic antibody (HA) interference remains a persistent challenge in immunoassay diagnostics. Human anti‐mouse antibodies (HAMA) can cause spuriously elevated biomarker results, potentially leading to misdiagnosis and unnecessary clinical interventions. Brain natriuretic peptide (BNP) is critical for heart failure diagnosis, but false‐positive results due to HAMA may trigger inappropriate clinical management. Case Presentation A 53 year‐old male with type 2 diabetes presented with markedly elevated BNP (4394–4419 pg/mL; reference < 100 pg/mL) by chemiluminescence immunoassay, despite no heart failure symptoms, normal ejection fraction (62%), and normal NT‐proBNP (55.8 pg/mL). This discordance prompted investigation for analytical interference.
Methods
Serial dilution (1:4, 1:8); specific blocking with mouse IgG, goat IgG, polymeric antibodies, and RF blocker; dose–response titration of mouse IgG (200–600 μg/mL); and alternative platform comparison.
Results
Serial dilution showed linear but incomplete recovery ( R 2 = 0.998), excluding hook effects. Mouse IgG induced a modest but specific 15.7% reduction in apparent BNP. Even 600 μg/mL mouse IgG achieved only partial blocking (residual BNP 2240 pg/mL), indicating high‐titer HAMA exceeding standard blocking capacity.
Conclusions
This case demonstrates extreme HAMA interference causing false‐positive BNP > 4000 pg/mL. Standard blocking reagents may be insufficient for high‐titer samples. When BNP is discordant with clinical status—especially with normal NT‐proBNP—laboratories must use systematic verification to prevent misdiagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People's Republic of China.
- Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People's Republic of China.
- Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People's Republic of China.
ORCID-Profile: Huicong Yang
Förderung
- Fujian Provincial Natural Science Foundation of China
Zitieren
APA
Yang, H., Zheng, Y., Zeng, Z., Gao, H., Wu, J., Wu, A., & Lin, J. (2026). Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol. Journal of Clinical Laboratory Analysis, 40(15). https://doi.org/10.1002/jcla.70280
Vancouver
Yang H, Zheng Y, Zeng Z, Gao H, Wu J, Wu A, et al. Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol. Journal of Clinical Laboratory Analysis. 2026;40(15). doi:10.1002/jcla.70280
BibTeX
@article{Yang2026,
author = {Yang, Huicong and Zheng, Yuanhai and Zeng, Zhenhua and Gao, Haimin and Wu, Jinzhi and Wu, Ayang and Lin, Jie},
title = {Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
volume = {40},
number = {15},
doi = {10.1002/jcla.70280}
}
EUVIMED